European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. epidemiology, diagnostics and prevention.

[1]  I. Zalaudek,et al.  The detection rate of human papillomavirus in well‐differentiated squamous cell carcinoma and keratoacanthoma: is there new evidence for a viral pathogenesis of keratoacanthoma? , 2019, The British journal of dermatology.

[2]  D. Whiteman,et al.  Aspirin and nonsteroidal anti‐inflammatory drug use and keratinocyte cancers: a large population‐based cohort study of skin cancer in Australia , 2019, The British journal of dermatology.

[3]  Matthew C. Fox,et al.  Nodal staging of high-risk cutaneous squamous cell carcinoma. , 2019, Journal of the American Academy of Dermatology.

[4]  C. Schmults,et al.  Performance of the American Joint Committee on Cancer Staging Manual, 8th Edition vs the Brigham and Women's Hospital Tumor Classification System for Cutaneous Squamous Cell Carcinoma. , 2019, JAMA dermatology.

[5]  M. Council,et al.  Topical and Systemic Modalities for Chemoprevention of Nonmelanoma Skin Cancer. , 2019, Dermatologic clinics.

[6]  S. Langan,et al.  Epidemiology of basal and cutaneous squamous cell carcinoma in the U.K. 2013–15: a cohort study , 2019, The British journal of dermatology.

[7]  M. Wallendorf,et al.  Skin cancer precursor immunotherapy for squamous cell carcinoma prevention. , 2019, JCI insight.

[8]  S. Slager,et al.  Comparison of tumor staging systems for cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia , 2019, Journal of the American Academy of Dermatology.

[9]  D. Brodland,et al.  Clinical outcomes in high‐risk squamous cell carcinoma patients treated with Mohs micrographic surgery alone , 2019, Journal of the American Academy of Dermatology.

[10]  M. Manabe,et al.  Incidence rate of cutaneous squamous cell carcinoma is rapidly increasing in Akita Prefecture: Urgent alert for super‐aged society , 2019, The Journal of dermatology.

[11]  Roger B. Davis,et al.  Reduced-Intensity Conditioning Regimens, Prior Chronic Lymphocytic Leukemia, and Graft-Versus-Host Disease Are Associated with Higher Rates of Skin Cancer after Allogeneic Hematopoietic Stem Cell Transplantation. , 2019, The Journal of investigative dermatology.

[12]  Katherine E Henson,et al.  Nationwide Incidence of Metastatic Cutaneous Squamous Cell Carcinoma in England , 2019, JAMA dermatology.

[13]  A. Fowler,et al.  A critical analysis of the prognostic performance of the 8th edition American Joint Committee on Cancer staging for metastatic cutaneous squamous cell carcinoma of the head and neck , 2019, Head & neck.

[14]  S. Arron,et al.  Keratinocyte Carcinomas: Current Concepts and Future Research Priorities , 2018, Clinical Cancer Research.

[15]  H. Williams,et al.  Reflectance confocal microscopy for diagnosing keratinocyte skin cancers in adults. , 2018, The Cochrane database of systematic reviews.

[16]  H. Williams,et al.  Optical coherence tomography for diagnosing skin cancer in adults. , 2018, The Cochrane database of systematic reviews.

[17]  I. Abraham,et al.  Staging Systems to Predict Metastatic Cutaneous Squamous Cell Carcinoma: Unsatisfactory for Clinical Use, but Some Less So? , 2018, JAMA dermatology.

[18]  Nilah M. Ioannidis,et al.  Gene expression imputation identifies candidate genes and susceptibility loci associated with cutaneous squamous cell carcinoma , 2018, Nature Communications.

[19]  M. Stratton,et al.  The genomic landscape of cutaneous SCC reveals drivers and a novel azathioprine associated mutational signature , 2018, Nature Communications.

[20]  R. Pujol,et al.  PD-L1 Expression is Increased in Metastasizing Squamous Cell Carcinomas and Their Metastases , 2018, The American Journal of dermatopathology.

[21]  E. Purdom,et al.  APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa , 2018, Science Translational Medicine.

[22]  G. Friedman,et al.  Photosensitizing antihypertensive drug use and risk of cutaneous squamous cell carcinoma , 2018, The British journal of dermatology.

[23]  E. Decullier,et al.  Sirolimus for Secondary Prevention of Skin Cancer in Kidney Transplant Recipients: 5-Year Results. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  L. Vercellino,et al.  Sentinel Lymph Node Biopsy in Cutaneous Squamous Cell Carcinoma Series of 37 Cases and Systematic Review of the Literature. , 2018, Acta dermato-venereologica.

[25]  S. Arron,et al.  Major prognostic factors for recurrence and survival independent of the American Joint Committee on Cancer eighth edition staging system in patients with cutaneous squamous cell carcinoma treated with multimodality therapy , 2018, Head & neck.

[26]  K. Morris,et al.  Prevalence of Skin Cancer Examination Among Users of Indoor Tanning Beds , 2018, JAMA dermatology.

[27]  O. Sanmartı́n,et al.  Systematic review of the prevalence of nodal metastases and the prognostic utility of sentinel lymph node biopsy in cutaneous squamous cell carcinoma , 2018, The Journal of dermatology.

[28]  P. Kraft,et al.  Quantifying the Polygenic Contribution to Cutaneous Squamous Cell Carcinoma Risk. , 2018, The Journal of investigative dermatology.

[29]  T. Gambichler,et al.  Cutaneous squamous cell carcinomas are associated with basal proliferating actinic keratoses , 2018, The British journal of dermatology.

[30]  V. Beral,et al.  Heterogeneous relationships of squamous and basal cell carcinomas of the skin with smoking: the UK Million Women Study and meta-analysis of prospective studies , 2018, British Journal of Cancer.

[31]  A. Hauschild,et al.  PD‐1 Blockade with Cemiplimab in Advanced Cutaneous Squamous‐Cell Carcinoma , 2018, The New England journal of medicine.

[32]  J. Utikal,et al.  Advanced cutaneous squamous cell carcinoma: A retrospective analysis of patient profiles and treatment patterns-Results of a non-interventional study of the DeCOG. , 2018, European journal of cancer.

[33]  V. Gebski,et al.  Immunocompromised patients with metastatic cutaneous nodal squamous cell carcinoma of the head and neck: Poor outcome unrelated to the index lesion , 2018, Head & neck.

[34]  P. Gjersvik,et al.  Validating 4 Staging Systems for Cutaneous Squamous Cell Carcinoma Using Population-Based Data: A Nested Case-Control Study , 2018, JAMA dermatology.

[35]  Linjie Zhang,et al.  Use of sunscreen and risk of melanoma and non-melanoma skin cancer: a systematic review and meta-analysis , 2018, European Journal of Dermatology.

[36]  C. Larsen,et al.  Risk of skin cancer in patients with HIV: A Danish nationwide cohort study , 2018, Journal of the American Academy of Dermatology.

[37]  Carrie D. Patnode,et al.  Behavioral Counseling for Skin Cancer Prevention: Evidence Report and Systematic Review for the US Preventive Services Task Force , 2018, JAMA.

[38]  Jonathan R. Clark,et al.  Predictive value of the 8th edition American Joint Commission Cancer (AJCC) nodal staging system for patients with cutaneous squamous cell carcinoma of the head and neck , 2018, Journal of surgical oncology.

[39]  Jiali Han,et al.  Use of antihypertensive drugs and risk of keratinocyte carcinoma: A meta‐analysis of observational studies , 2018, Pharmacoepidemiology and drug safety.

[40]  B. Mittal,et al.  Guidelines of care for the management of cutaneous squamous cell carcinoma. , 2018, Journal of the American Academy of Dermatology.

[41]  V. Varki,et al.  PD-L1, B7-H3, and PD-1 expression in immunocompetent vs. immunosuppressed patients with cutaneous squamous cell carcinoma , 2018, Cancer Immunology, Immunotherapy.

[42]  Grant D. Huang,et al.  Chemoprevention of Basal and Squamous Cell Carcinoma With a Single Course of Fluorouracil, 5%, Cream: A Randomized Clinical Trial , 2018, JAMA dermatology.

[43]  C. Schmults,et al.  Cutaneous squamous cell carcinoma: Incidence, risk factors, diagnosis, and staging. , 2018, Journal of the American Academy of Dermatology.

[44]  Lucia Miligi,et al.  Anti-hypertensive drugs and skin cancer risk: a review of the literature and meta-analysis. , 2018, Critical reviews in oncology/hematology.

[45]  Jonathan R. Clark,et al.  Analysis and Comparison of the 8th Edition American Joint Committee on Cancer (AJCC) Nodal Staging System in Cutaneous and Oral Squamous Cell Cancer of the Head and Neck , 2018, Annals of Surgical Oncology.

[46]  J. Califano,et al.  Comparison of Tumor Classifications for Cutaneous Squamous Cell Carcinoma of the Head and Neck in the 7th vs 8th Edition of the AJCC Cancer Staging Manual , 2017, JAMA dermatology.

[47]  A. Pottegård,et al.  Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide case‐control study from Denmark , 2017, Journal of the American Academy of Dermatology.

[48]  C. Garbe,et al.  Survival of Patients with Cutaneous Squamous Cell Carcinoma: Results of a Prospective Cohort Study. , 2017, The Journal of investigative dermatology.

[49]  S. Arron,et al.  Research gaps in the management and prevention of cutaneous squamous cell carcinoma in organ transplant recipients , 2017, The British journal of dermatology.

[50]  S. Arron,et al.  Organ transplantation and cutaneous squamous cell carcinoma: progress, pitfalls and priorities in immunosuppression‐associated keratinocyte carcinoma , 2017, The British journal of dermatology.

[51]  R. Ashton,et al.  Low incidence of metastasis and recurrence from cutaneous squamous cell carcinoma found in a UK population: Do we need to adjust our thinking on this rare but potentially fatal event? , 2017, Journal of surgical oncology.

[52]  C. Longo,et al.  Dermoscopic and reflectance confocal microscopy features of cutaneous squamous cell carcinoma , 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.

[53]  A. Whittemore,et al.  Susceptibility Loci-Associated Cutaneous Squamous Cell Carcinoma Invasiveness. , 2017, The Journal of investigative dermatology.

[54]  G Pellacani,et al.  In vivo microvascular imaging of cutaneous actinic keratosis, Bowen's disease and squamous cell carcinoma using dynamic optical coherence tomography , 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.

[55]  D. Whiteman,et al.  The incidence and multiplicity rates of keratinocyte cancers in Australia , 2017, The Medical journal of Australia.

[56]  Ling Peng,et al.  Incidence and relative risk of cutaneous squamous cell carcinoma with single-agent BRAF inhibitor and dual BRAF/MEK inhibitors in cancer patients: a meta-analysis , 2017, Oncotarget.

[57]  M. Asgari,et al.  Association of Multiple Primary Skin Cancers With Human Immunodeficiency Virus Infection, CD4 Count, and Viral Load , 2017, JAMA dermatology.

[58]  C. Schmults,et al.  Clinical and Incidental Perineural Invasion of Cutaneous Squamous Cell Carcinoma: A Systematic Review and Pooled Analysis of Outcomes Data , 2017, JAMA dermatology.

[59]  D. Whiteman,et al.  Cigarette Smoking and the Risks of Basal Cell Carcinoma and Squamous Cell Carcinoma. , 2017, The Journal of investigative dermatology.

[60]  D. Czarnecki.  Non‐melanoma skin cancer mortality rising in susceptible Australians , 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.

[61]  C. Reddy,et al.  A multi‐institutional comparison of outcomes of immunosuppressed and immunocompetent patients treated with surgery and radiation therapy for cutaneous squamous cell carcinoma of the head and neck , 2017, Cancer.

[62]  A. Weaver,et al.  Incidence and Trends of Basal Cell Carcinoma and Cutaneous Squamous Cell Carcinoma: A Population‐Based Study in Olmsted County, Minnesota, 2000 to 2010 , 2017, Mayo Clinic proceedings.

[63]  R. Gutzmer,et al.  The pattern and clinicopathological correlates of programmed death‐ligand 1 expression in cutaneous squamous cell carcinoma , 2017, The British journal of dermatology.

[64]  D. Greenberg,et al.  Predicted cases of U.K. skin squamous cell carcinoma and basal cell carcinoma in 2020 and 2025: horizon planning for National Health Service dermatology and dermatopathology , 2017, The British journal of dermatology.

[65]  Nilah M. Ioannidis,et al.  Cutaneous squamous cell cancer (cSCC) risk and the human leukocyte antigen (HLA) system. , 2017, Human immunology.

[66]  A. Wysong,et al.  The role of imaging in the management of patients with nonmelanoma skin cancer: Diagnostic modalities and applications. , 2017, Journal of the American Academy of Dermatology.

[67]  A. Wysong,et al.  The role of imaging in the management of patients with nonmelanoma skin cancer: When is imaging necessary? , 2017, Journal of the American Academy of Dermatology.

[68]  J. Stein,et al.  Incidence of and Risk Factors for Skin Cancer in Organ Transplant Recipients in the United States , 2017, JAMA dermatology.

[69]  A. Green,et al.  Cutaneous squamous cell carcinoma: an epidemiological review , 2017, The British journal of dermatology.

[70]  M. Weinstock,et al.  Reply to ‘A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients’ , 2017, The British journal of dermatology.

[71]  C. Schmults,et al.  The positive impact of radiologic imaging on high‐stage cutaneous squamous cell carcinoma management , 2017, Journal of the American Academy of Dermatology.

[72]  R. Scolyer,et al.  Authors' response to a reply to ‘A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients’ , 2017, The British journal of dermatology.

[73]  S. Tyring,et al.  Association Between β-Genus Human Papillomavirus and Cutaneous Squamous Cell Carcinoma in Immunocompetent Individuals-A Meta-analysis. , 2016, JAMA dermatology.

[74]  R. Scolyer,et al.  A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients , 2016, The British journal of dermatology.

[75]  Randy W. Elder,et al.  Community-based Interventions to Prevent Skin Cancer: Two Community Guide Systematic Reviews , 2016 .

[76]  T. Diepgen.  New developments in occupational dermatology , 2016, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[77]  Erika J. Thompson,et al.  Cross-species identification of genomic drivers of squamous cell carcinoma development across preneoplastic intermediates , 2016, Nature Communications.

[78]  H. Clevers,et al.  Inactivation of TGFβ receptors in stem cells drives cutaneous squamous cell carcinoma , 2016, Nature Communications.

[79]  J. Strasswimmer,et al.  Hedgehog Pathway Inhibitor Therapy for Locally Advanced and Metastatic Basal Cell Carcinoma: A Systematic Review and Pooled Analysis of Interventional Studies. , 2016, JAMA dermatology.

[80]  B. Panizza,et al.  Outcomes after surgery and postoperative radiotherapy for perineural spread of head and neck cutaneous squamous cell carcinoma , 2016, Head & neck.

[81]  Joyce Y. Cheng,et al.  Cutaneous squamous cell carcinomas in solid organ transplant recipients: emerging strategies for surveillance, staging, and treatment. , 2016, Seminars in oncology.

[82]  A. Rustgi,et al.  Squamous Cell Cancers: A Unified Perspective on Biology and Genetics. , 2016, Cancer cell.

[83]  A. Henry,et al.  Increased Risk of Cutaneous Squamous Cell Carcinoma After Vismodegib Therapy for Basal Cell Carcinoma. , 2016, JAMA dermatology.

[84]  S. Whitaker,et al.  Non-melanoma skin cancer: United Kingdom National Multidisciplinary Guidelines , 2016, The Journal of Laryngology & Otology.

[85]  M. Murad,et al.  Risk Factors for Cutaneous Squamous Cell Carcinoma Recurrence, Metastasis, and Disease-Specific Death: A Systematic Review and Meta-analysis. , 2016, JAMA dermatology.

[86]  Jonathan R. Clark,et al.  Prospective study of sentinel node biopsy for high‐risk cutaneous squamous cell carcinoma of the head and neck , 2016, Head & neck.

[87]  R. Gniadecki,et al.  Skin Cancer Risk in Hematopoietic Stem-Cell Transplant Recipients Compared With Background Population and Renal Transplant Recipients: A Population-Based Cohort Study. , 2016, JAMA dermatology.

[88]  P. Stephens,et al.  Evaluation of 122 advanced‐stage cutaneous squamous cell carcinomas by comprehensive genomic profiling opens the door for new routes to targeted therapies , 2016, Cancer.

[89]  R. Scolyer,et al.  A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention. , 2015, The New England journal of medicine.

[90]  S. Arron,et al.  Sirolimus use and risk of cutaneous squamous cell carcinoma (SCC) in solid organ transplant recipients (SOTRs). , 2015, Journal of the American Academy of Dermatology.

[91]  I. Zalaudek,et al.  Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline. , 2015, European journal of cancer.

[92]  R. Hofmann-Wellenhof,et al.  High‐definition optical coherence tomography algorithm for the discrimination of actinic keratosis from normal skin and from squamous cell carcinoma , 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

[93]  P. Uribe,et al.  High-risk cutaneous squamous cell carcinoma and the emerging role of sentinel lymph node biopsy: A literature review. , 2015, Journal of the American Academy of Dermatology.

[94]  C. Surber,et al.  Nonsteroidal anti‐inflammatory drugs and the risk of nonmelanoma skin cancer , 2015, International journal of cancer.

[95]  R. Hofmann-Wellenhof,et al.  The clinical and dermoscopic features of invasive cutaneous squamous cell carcinoma depend on the histopathological grade of differentiation , 2015, The British journal of dermatology.

[96]  A. Ariza,et al.  Actinic keratosis with atypical basal cells (AK I) is the most common lesion associated with invasive squamous cell carcinoma of the skin , 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

[97]  A. Green,et al.  Aspirin and nonsteroidal anti-inflammatory drugs can prevent cutaneous squamous cell carcinoma: a systematic review and meta-analysis. , 2015, The Journal of investigative dermatology.

[98]  M. Beyer,et al.  Sentinel lymph node biopsy and risk factors for predicting metastasis in cutaneous squamous cell carcinoma , 2015, The British journal of dermatology.

[99]  D. Rowell,et al.  Health system costs of skin cancer and cost-effectiveness of skin cancer prevention and screening: a systematic review , 2015, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[100]  J. Cerhan,et al.  Increased incidence and recurrence rates of nonmelanoma skin cancer in patients with non-Hodgkin lymphoma: a Rochester Epidemiology Project population-based study in Minnesota. , 2015, Journal of the American Academy of Dermatology.

[101]  Monika Janda,et al.  Can skin cancer prevention and early detection be improved via mobile phone text messaging? A randomised, attention control trial. , 2015, Preventive medicine.

[102]  A. Khachemoune,et al.  Squamous cell carcinoma of the skin: epidemiology, classification, management, and novel trends , 2015, International journal of dermatology.

[103]  J. E. Allen,et al.  Utility of sentinel node biopsy in patients with high-risk cutaneous squamous cell carcinoma. , 2015, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[104]  M. Veierød,et al.  Cutaneous squamous cell carcinoma in norway 1963–2011: increasing incidence and stable mortality , 2015, Cancer medicine.

[105]  G. Knoll,et al.  Effect of sirolimus on malignancy and survival after kidney transplantation: systematic review and meta-analysis of individual patient data , 2014, BMJ : British Medical Journal.

[106]  H. Comber,et al.  Increasing skin cancer incidence in young, affluent, urban populations: a challenge for prevention , 2014, The British journal of dermatology.

[107]  S. Shiraishi,et al.  Evaluation of sentinel node biopsy for cutaneous squamous cell carcinoma , 2014, The Journal of dermatology.

[108]  J. Maize,et al.  Keratoacanthoma Clinical Behavior: A Systematic Review , 2014, The American Journal of dermatopathology.

[109]  C. Newlands,et al.  Management of regional metastatic disease in head and neck cutaneous malignancy. 1. Cutaneous squamous cell carcinoma. , 2014, The British journal of oral & maxillofacial surgery.

[110]  S. Arron,et al.  NOTCH1 mutations occur early during cutaneous squamous cell carcinogenesis , 2014, The Journal of investigative dermatology.

[111]  M. Davids,et al.  Association of advanced leukemic stage and skin cancer tumor stage with poor skin cancer outcomes in patients with chronic lymphocytic leukemia. , 2014, JAMA dermatology.

[112]  A. Qureshi,et al.  Evaluation of American Joint Committee on Cancer, International Union Against Cancer, and Brigham and Women's Hospital tumor staging for cutaneous squamous cell carcinoma. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[113]  T. Shpitzer,et al.  Cancer of the head and neck region in solid organ transplant recipients , 2014, Head & neck.

[114]  R. Kefford,et al.  Systemic retinoids for the chemoprevention of cutaneous squamous cell carcinoma and verrucal keratosis in a cohort of patients on BRAF inhibitors , 2013, The British journal of dermatology.

[115]  Alana D. Steffen,et al.  Randomized Trial of Tailored Skin Cancer Prevention for Children: The Project SCAPE Family Study , 2013, Journal of health communication.

[116]  J. Carucci.  Press for an underestimated nemesis. , 2013, JAMA dermatology.

[117]  E. Stockfleth,et al.  The natural history of actinic keratosis: a systematic review , 2013, The British journal of dermatology.

[118]  David T. W. Jones,et al.  Signatures of mutational processes in human cancer , 2013, Nature.

[119]  Jiali Han,et al.  Cutaneous squamous cell carcinoma: estimated incidence of disease, nodal metastasis, and deaths from disease in the United States, 2012. , 2013, Journal of the American Academy of Dermatology.

[120]  A. Qureshi,et al.  Factors predictive of recurrence and death from cutaneous squamous cell carcinoma: a 10-year, single-institution cohort study. , 2013, JAMA dermatology.

[121]  D. Jayne,et al.  SUMMARY OF PRODUCT CHARACTERISTICS , 2014 .

[122]  W. Hwang,et al.  Evaluation of AJCC tumor staging for cutaneous squamous cell carcinoma and a proposed alternative tumor staging system. , 2013, JAMA dermatology.

[123]  M. Raftery,et al.  A Surveillance Model for Skin Cancer in Organ Transplant Recipients: A 22‐Year Prospective Study in an Ethnically Diverse Population , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[124]  I. Zalaudek,et al.  Dermoscopy of squamous cell carcinoma and keratoacanthoma. , 2012, Archives of dermatology.

[125]  E. Dennett,et al.  The incidence of metastasis from cutaneous squamous cell carcinoma and the impact of its risk factors , 2012, Journal of surgical oncology.

[126]  B. Panizza,et al.  Surgical resection for clinical perineural invasion from cutaneous squamous cell carcinoma of the head and neck , 2012, Head & neck.

[127]  H. Breuninger,et al.  Comparison and evaluation of the current staging of cutaneous carcinomas , 2012, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[128]  M. Weinstock,et al.  Tretinoin and the prevention of keratinocyte carcinoma (Basal and squamous cell carcinoma of the skin): a veterans affairs randomized chemoprevention trial. , 2012, The Journal of investigative dermatology.

[129]  J. Leonardi-Bee,et al.  A systematic review of worldwide incidence of nonmelanoma skin cancer , 2012, The British journal of dermatology.

[130]  G. Russ,et al.  Randomized Controlled Trial of Sirolimus for Renal Transplant Recipients at High Risk for Nonmelanoma Skin Cancer , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[131]  P. Novotny,et al.  Randomized controlled trial of acitretin versus placebo in patients at high‐risk for basal cell or squamous cell carcinoma of the skin (North Central Cancer Treatment Group Study 969251) , 2012, Cancer.

[132]  Harald Kittler,et al.  Dermatoscopy of facial actinic keratosis, intraepidermal carcinoma, and invasive squamous cell carcinoma: a progression model. , 2012, Journal of the American Academy of Dermatology.

[133]  K. Flaherty,et al.  RAS mutations in cutaneous squamous-cell carcinomas in patients treated with BRAF inhibitors. , 2012, The New England journal of medicine.

[134]  J. Paoli,et al.  Incidence of cutaneous squamous cell carcinoma in coastal and inland areas of Western Sweden. , 2011, Cancer epidemiology.

[135]  C Beauvillain,et al.  Guidelines for the diagnosis and treatment of cutaneous squamous cell carcinoma and precursor lesions , 2011, Journal of the European Academy of Dermatology and Venereology : JEADV.

[136]  J. Manson,et al.  Calcium plus vitamin D supplementation and the risk of nonmelanoma and melanoma skin cancer: post hoc analyses of the women's health initiative randomized controlled trial. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[137]  M. Gandhi,et al.  Detecting and defining the anatomic extent of large nerve perineural spread of malignancy: Comparing “targeted” MRI with the histologic findings following surgery , 2011, Head & neck.

[138]  Michelle E. Kho,et al.  AGREE II: advancing guideline development, reporting and evaluation in health care , 2010, Canadian Medical Association Journal.

[139]  Bruce E. Stuck,et al.  ICNIRP STATEMENT—PROTECTION OF WORKERS AGAINST ULTRAVIOLET RADIATION , 2010, Health physics.

[140]  Beth A. Glenn,et al.  The sun sense study: an intervention to improve sun protection in children. , 2010, American journal of health behavior.

[141]  Chao Zhang,et al.  RAF inhibitors transactivate RAF dimers and ERK signaling in cells with wild-type BRAF , 2010, Nature.

[142]  J. Reis-Filho,et al.  Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAF , 2010, Cell.

[143]  E. Stockfleth,et al.  Certification of sun protection practices in a German child day‐care centre improves children’s sun protection – the ‘SunPass’ pilot study , 2009, The British journal of dermatology.

[144]  Christi Alessi Fox,et al.  Reflectance confocal microscopy criteria for squamous cell carcinomas and actinic keratoses. , 2009, Archives of dermatology.

[145]  B. Schönfisch,et al.  Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. , 2008, The Lancet. Oncology.

[146]  G. Halliday,et al.  UV radiation-induced immunosuppression is greater in men and prevented by topical nicotinamide. , 2008, The Journal of investigative dermatology.

[147]  J. V. van Engelshoven,et al.  Detection of lymph node metastases in head and neck cancer: a meta-analysis comparing US, USgFNAC, CT and MR imaging. , 2007, European journal of radiology.

[148]  P. G. Lang,et al.  Sentinel Lymph Node Biopsy for High‐Risk Nonmelanoma Skin Cancers , 2007, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[149]  P. Pasquini,et al.  Sentinel lymph node biopsy for high risk cutaneous squamous cell carcinoma: case series and review of the literature. , 2007, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[150]  K. Patrick,et al.  A randomized trial of a multicomponent intervention for adolescent sun protection behaviors. , 2007, Archives of pediatrics & adolescent medicine.

[151]  Gail M. Williams,et al.  Prolonged Prevention of Squamous Cell Carcinoma of the Skin by Regular Sunscreen Use , 2006, Cancer Epidemiology Biomarkers & Prevention.

[152]  C. Schmults,et al.  Sentinel Lymph Node Biopsy in Cutaneous Squamous Cell Carcinoma: A Systematic Review of the English Literature , 2006, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[153]  R. Dellavalle,et al.  A randomized intervention study of sun protection promotion in well-child care. , 2006, Preventive medicine.

[154]  M. Thissen,et al.  Histopathological characteristics of metastasizing squamous cell carcinoma of the skin and lips , 2006, Histopathology.

[155]  M. Pittelkow,et al.  Increased metastasis and mortality from cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia. , 2005, Journal of the American Academy of Dermatology.

[156]  C. Proby,et al.  Low-dose retinoids in the prevention of cutaneous squamous cell carcinomas in organ transplant recipients: a 16-year retrospective study. , 2005, Archives of dermatology.

[157]  S. Shumack,et al.  Oral retinoids for the prevention of skin cancers in solid organ transplant recipients: a systematic review of randomized controlled trials , 2005, The British journal of dermatology.

[158]  R. Hiatt,et al.  Interventions to prevent skin cancer by reducing exposure to ultraviolet radiation: a systematic review. , 2004, American journal of preventive medicine.

[159]  R. Stern,et al.  Oral retinoid use reduces cutaneous squamous cell carcinoma risk in patients with psoriasis treated with psoralen-UVA: a nested cohort study. , 2003, Journal of the American Academy of Dermatology.

[160]  N. Fenske,et al.  Utility of Sentinel Lymphadenectomy in the Management of Patients With High‐Risk Cutaneous Squamous Cell Carcinoma , 2003, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[161]  P. G. Lang,et al.  Prognostic Factors for Metastasis in Squamous Cell Carcinoma of the Skin , 2002, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[162]  M Hewitt,et al.  Evaluation of 'Sun-safe': a health education resource for primary schools. , 2001, Health education research.

[163]  C. Sinclair,et al.  Slip! Slop! Slap! and SunSmart, 1980-2000: Skin Cancer Control and 20 Years of Population-Based Campaigning , 2001, Health education & behavior : the official publication of the Society for Public Health Education.

[164]  D Ratner,et al.  Cutaneous squamous-cell carcinoma. , 2001, The New England journal of medicine.

[165]  W. Mendenhall,et al.  Perineural spread of cutaneous squamous and basal cell carcinoma: CT and MR detection and its impact on patient management and prognosis. , 2001, International journal of radiation oncology, biology, physics.

[166]  P. Shepherd,et al.  Ber EP4 and epithelial membrane antigen aid distinction of basal cell, squamous cell and basosquamous carcinomas of the skin , 2000, Histopathology.

[167]  Gail M. Williams,et al.  Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial , 1999, The Lancet.

[168]  Donald R. Miller,et al.  The Falmouth Safe Skin Project: Evaluation of a Community Program to Promote Sun Protection in Youth , 1999, Health education & behavior : the official publication of the Society for Public Health Education.

[169]  U. Haustein,et al.  Squamous cell carcinoma of the skin ‐ histopathological features and their significance for the clinical outcome , 1998, Journal of the European Academy of Dermatology and Venereology : JEADV.

[170]  W. Harmsen,et al.  Trends in the population-based incidence of squamous cell carcinoma of the skin first diagnosed between 1984 and 1992. , 1997, Archives of dermatology.

[171]  H. Breuninger,et al.  Desmoplastic squamous cell carcinoma of skin and vermilion surface , 1997, Cancer.

[172]  R. Marks,et al.  Squamous cell carcinoma , 1996, The Lancet.

[173]  R N Hoover,et al.  The emerging epidemic of melanoma and squamous cell skin cancer. , 1989, JAMA.

[174]  G. Rennie,et al.  MALIGNANT TRANSFORMATION OF SOLAR KERATOSES TO SQUAMOUS CELL CARCINOMA , 1988, The Lancet.

[175]  C. Ko,et al.  Cutaneous Squamous Cell Carcinomas in Solid Organ Transplant Recipients Compared With Immunocompetent Patients , 2018, JAMA dermatology.

[176]  Steven He,et al.  Trends of skin cancer mortality after transplantation in the United States: 1987 to 2013. , 2016, Journal of the American Academy of Dermatology.

[177]  J. Brewer,et al.  Staging for cutaneous squamous cell carcinoma as a predictor of sentinel lymph node biopsy results: meta-analysis of American Joint Committee on Cancer criteria and a proposed alternative system. , 2014, JAMA dermatology.

[178]  Matthew M. Johnson,et al.  Outcomes of primary cutaneous squamous cell carcinoma with perineural invasion: an 11-year cohort study. , 2013, JAMA dermatology.

[179]  van der Waal Ri,et al.  Squamous cell carcinoma , 2012 .

[180]  D. Brizel,et al.  National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology , 2012 .

[181]  S. Sohaib,et al.  Routine computerized tomography scanning, groin ultrasound with or without fine needle aspiration cytology in the surgical management of primary squamous cell carcinoma of the vulva , 2004, International Journal of Gynecologic Cancer.

[182]  L. Aiken,et al.  Evaluation of a multicomponent appearance-based sun-protective intervention for young women: uncovering the mechanisms of program efficacy. , 2006, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[183]  Peter Kraft,et al.  Genome-wide association study identifies novel susceptibility loci for cutaneous squamous cell carcinoma , 2022 .